General Shareholders' Meeting 2025
Access all the information about Grifols’ 2025 Annual General Meeting.
Showing 232 search results
Grifols discloses transfers of value made to European healthcare professionals and healthcare organizations in 2024
Grifols’ positive fibrinogen phase 3 trial results published in The Lancet’s eClinicalMedicine
Grifols successfully completes Biotest delisting
Anne-Catherine Berner, new Grifols Chair
Grifols celebrates 25th anniversary of its Diagnostic R&D center in Bizkaia, a key driver of its sector leadership
Grifols receives FDA clearance of IND application for Phase 2 trial of immunoglobulin drops for dry eye disease
Publications
Links to our latest financial and sustainability reports and other recent publications.
Financial Report
Explore our last financial and earnings report.
Sustainability Report
Integrated and Sustainability Annual Report.
Position Paper
The differential value of plasma-derived medicinal products (PDMPs).
Press Kit
Explore our Press Kit to find key facts and figures on Grifols.
Media Contacts
If you're a journalist or media professional with a question, contact our media relations team.